B. Riley Wealth Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,469
Closed -$278K 567
2017
Q1
$278K Sell
3,469
-142
-4% -$11.3K 0.06% 365
2016
Q4
$285K Sell
3,611
-133
-4% -$10.3K 0.06% 360
2016
Q3
$292K Sell
3,744
-3
-0.1% -$218 0.06% 409
2016
Q2
$258K Sell
3,747
-24
-0.6% -$1.66K 0.05% 454
2016
Q1
$269K Buy
3,771
+212
+6% +$13.3K 0.06% 378
2015
Q4
$222K Buy
+3,559
New +$217K 0.05% 463
2015
Q1
Sell
-6
Closed 2200
2014
Q4
$0 Buy
+6
New +$245 ﹤0.01% 3773
2014
Q3
Sell
-6
Closed -$226 2071
2014
Q2
$226 Buy
+6
New +$204 ﹤0.01% 2421

Other funds holding CMD

B. Riley Wealth Advisors's CMD Position: Q2 2017 in Review

B. Riley Wealth Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 3,469 shares — an estimated $278K sold.

B. Riley Wealth Advisors first reported a position in CMD in Q2 2014 and held it in 8 quarters. The position peaked at $292K in Q3 2016. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • B. Riley Wealth Advisors reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 3,469 Cantel Medical Corporation shares in Q2 2017, an estimated $278K.
  • B. Riley Wealth Advisors first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 8 quarters.
  • B. Riley Wealth Advisors's Cantel Medical Corporation position peaked at $292K in Q3 2016.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.